Anavex to present at Rodman & Renshaw Healthcare Conference September 13 in New York
Sources News Release
Publisher: Dr. Cameron Durrant, MD, MBA, Alzheimer's Disease and Pharmaceuticals/Biot
Date Written: 08/09/2010
Year Published: 2010
Resource Type: Article
Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL) is pleased to announce that Dr. Cameron Durrant, the company#s Executive Chairman, will be presenting at the Rodman & Renshaw 12th Annual Healthcare Conference at 4:45 pm ET on Monday, September 13
Abstract: CALIFON, NJ # September 8, 2010 -- Dr. Cameron Durrant, Executive Chairman of Anavex Life Sciences Corp. (#Anavex#) (OTCBB: AVXL), will be presenting at the Rodman & Renshaw 12th Annual Healthcare Conference at 4:45 pm ET on Monday, September 13, 2010 in New York City. He will discuss ANAVEX 2-73, the company#s lead compound for the treatment of Alzheimer#s disease entering clinical trials, and the business case for Anavex.
Investors can register for free admission by following the instruc...
To read the full release go to http://www.sources.com/Releases/NR972.htm
© 2019. The information provided is copyright and may not be reproduced in any form or by any means (whether electronic, mechanical or photographic), or stored in an electronic retrieval system, without written permission of the publisher. The content may not be resold, republished, or redistributed. Indexing and search applications by Ulli Diemer and Chris DeFreitas.